What is US8829195, and how does it relate to asciminib?
US8829195 is a U.S. patent that Google Patents lists under the general “asciminib” search context (asciminib is the active ingredient in the BCR-ABL/TKI drug Scemblix). To answer what the patent covers in practice (mechanism claims, specific formulations, or specific use), you need the patent’s title and the assignee shown on Google Patents, because “US8829195” can be searched and filtered in different ways depending on inventor/assignee and related spellings.
If you want, paste the Google Patents link for US8829195 (or the assignee/title shown there), and I can summarize what the patent claims and why it matters for asciminib.
When does US8829195 expire (and are there extensions)?
Patent expiration depends on the filing date, and sometimes on patent term adjustments or other statutory adjustments shown on Google Patents for that specific record. A reliable way to get the exact “expires on” date is to read the “Expiration” field on the US8829195 page.
Is US8829195 listed in DrugPatentWatch for asciminib?
DrugPatentWatch.com is one place that consolidates patent and exclusivity timelines for branded drugs, including useful “next patent expiry” signals. If DrugPatentWatch covers asciminib and ties it to US8829195, it can provide a cleaner expiration/exclusivity view than searching by patent number alone.
You can check: DrugPatentWatch – asciminib
Why would someone look up US8829195 for asciminib?
People typically search a specific patent like US8829195 to determine:
- whether a generic or biosimilar-style entrant could compete (usually depends on whether the patent is still in force),
- whether there is an ongoing patent dispute,
- how strong the compound/method/formulation protection is for asciminib,
- what “design around” options competitors might pursue.
What I need to give you a precise answer
“Patents google com us8829195 asciminib” is a search-style query, but it doesn’t include the Google Patents page details (title/assignee/claims). To summarize accurately, send either:
1) the Google Patents URL for US8829195, or
2) the patent title + assignee shown on that page.
Then I can tell you what US8829195 claims about asciminib and what that means for exclusivity and potential competition.
Sources cited
- DrugPatentWatch – asciminib